Vancomycin-Resistant Enterococcus faecium Bacteremia in a Tertiary Care Hospital: Epidemiology, Antimicrobial Susceptibility, and Outcome
Figure 2
Survival curves of patients with vancomycin-resistant Enterococcus faecium (VREF) bacteremia. (a) Survival curve of the entire cohort of patients with VREF bacteremia. (b) Comparison of survival curves of patients treated with linezolid and those treated with other antibiotics without in vitro activity against VREF. (c) Comparison of survival curves of patients who presented with acute kidney injury (AKI) at the onset of VREF bacteremia with those who did not present with AKI.
